ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Ecolab Life Sciences Introduces Klercide™ Rapid Sporicide for Cleanroom Applications

New solution reduces time and costs to meet the modern demands of pharmaceutical production

Ecolab Life Sciences today announced the launch of its Klercide™ Rapid Sporicide, a new sporicidal disinfectant designed to elevate pharmaceutical cleanroom safety and performance, while reducing overall production turnover time. This new pharma cleanroom product is milder on equipment and surfaces and helps improve user experience along with work conditions.

Ecolab’s latest pharma cleanroom sporicide addresses long-standing challenges in pharma microbial control, like strong odors, corrosiveness, and full surface coverage, all of which contribute to a reduced lifetime of equipment and a less desirable work environment for operators. This new formula is a market-changing innovation, delivering efficacy while minimizing residue, reducing re-application time and enhancing the overall user experience. This leads to shorter changeover times and overall savings for pharmaceutical manufacturers, helping deliver safely made medicines to patients faster. The new sporicide will be available in a variety of formats to meet the entire lifecycle of pharma production.

“Cleanroom operators and pharmaceutical manufacturers have long sought a sporicide solution that balances efficacy and usability, without the strong odor or corrosiveness associated with existing solutions,” said Meg Carr, vice president & general manager, Ecolab Life Sciences. “Klercide Rapid Sporicide represents a significant advancement in cleanroom contamination control and underpins Ecolab’s commitment to creating a measurable impact in safe manufacturing.”

Klercide Rapid Sporicide is registered with the Environmental Protection Agency (EPA Reg. No. 1677-288) for use against bacterial spores, fungi, and other hard-to-kill microorganisms. State registrations are in process.

Further information regarding the new solution can also be viewed at the Ecolab Life Sciences website here.

About Ecolab

A trusted partner for millions of customers, Ecolab (NYSE: ECL) is a global sustainability leader offering water, hygiene and infection prevention solutions and services that protect people and the resources vital to life. Building on more than a century of innovation, Ecolab has annual sales of $16 billion, employs approximately 48,000 associates and operates in more than 170 countries around the world. The company delivers comprehensive science-based solutions, data-driven insights and world-class service to advance food safety, maintain clean and safe environments, and optimize water and energy use. Ecolab’s innovative solutions improve operational efficiencies and sustainability for customers in the food, healthcare, high tech, life sciences, hospitality and industrial markets.

www.ecolab.com

Follow us on LinkedIn @Ecolab, Instagram @Ecolab_Inc and Facebook @Ecolab.

(ECL-C)

This new formula is a market-changing innovation, delivering efficacy while minimizing residue, reducing re-application time and enhancing the overall user experience.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.40
+3.99 (1.63%)
AAPL  269.43
+0.96 (0.36%)
AMD  243.98
+10.44 (4.47%)
BAC  53.42
+0.22 (0.41%)
GOOG  290.59
+10.89 (3.89%)
META  631.76
+10.05 (1.62%)
MSFT  506.00
+9.18 (1.85%)
NVDA  199.05
+10.90 (5.79%)
ORCL  240.83
+1.57 (0.66%)
TSLA  445.23
+15.71 (3.66%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.